-+ 0.00%
-+ 0.00%
-+ 0.00%

argenx Halts Phase 3 UplighTED Trials of Efgartigimod in Thyroid Eye Disease After Futility Analysis

Reuters·12/15/2025 06:00:29

Please log in to view news